US Compound Feed Market

ID: MRFR/Agri/19202-HCR 128 Pages Snehal Singh Last Updated: September 10, 2026

US Compound Feed Market Size, Share, Industry Trend & Analysis Research Report: By Ingredients (Cereals, Cereal By-Products, Oilseed Meal, Oils, Molasses, Supplements, Others), By Supplements (Vitamins, Antibiotics, Antioxidants, Amino Acids, Enzymes, Acidifiers, Others) andBy Livestock (Ruminants, Swine, Poultry, Aquaculture, Others)- Forecast to 2035

US Compound Feed Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.29%
2024 Market Size$ 109 Billion
2025 Market Size$ 113.68 Billion
2035 Market Size$ 173 Billion
Key Players
Cargill
Archer Daniels Midland
Nutreco
Alltech
BASF
De Heus
Opportunities
  • Growth of the Pet Food Sector
  • Rising Demand for Animal Protein
  • Regulatory Support for Feed Quality
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Ingredients (USD Billion)
      1. 4.1.1 Cereals
      2. 4.1.2 Cereal By-Products
      3. 4.1.3 Oilseed Meal
      4. 4.1.4 Oils
      5. 4.1.5 Molasses
      6. 4.1.6 Supplements
      7. 4.1.7 Others
    2. 4.2 Pharmaceutical, BY Supplements (USD Billion)
      1. 4.2.1 Vitamins
      2. 4.2.2 Antibiotics
      3. 4.2.3 Antioxidants
      4. 4.2.4 Amino Acids
      5. 4.2.5 Enzymes
      6. 4.2.6 Acidifiers
      7. 4.2.7 Others
    3. 4.3 Pharmaceutical, BY Livestock (USD Billion)
      1. 4.3.1 Ruminants
      2. 4.3.2 Swine
      3. 4.3.3 Poultry
      4. 4.3.4 Aquaculture
      5. 4.3.5 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cargill (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Archer Daniels Midland (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Nutreco (NL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Alltech (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 BASF (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 De Heus (NL)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 ForFarmers (NL)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Land O'Lakes (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Charoen Pokphand Foods (TH)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY INGREDIENTS
    3. 6.3 US MARKET ANALYSIS BY SUPPLEMENTS
    4. 6.4 US MARKET ANALYSIS BY LIVESTOCK
    5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
    8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    11. 6.11 PHARMACEUTICAL, BY INGREDIENTS, 2024 (% SHARE)
    12. 6.12 PHARMACEUTICAL, BY INGREDIENTS, 2024 TO 2035 (USD Billion)
    13. 6.13 PHARMACEUTICAL, BY SUPPLEMENTS, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY SUPPLEMENTS, 2024 TO 2035 (USD Billion)
    15. 6.15 PHARMACEUTICAL, BY LIVESTOCK, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY LIVESTOCK, 2024 TO 2035 (USD Billion)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY INGREDIENTS, 2025-2035 (USD Billion)
      2. 7.2.2 BY SUPPLEMENTS, 2025-2035 (USD Billion)
      3. 7.2.3 BY LIVESTOCK, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Compound Feed Market Segmentation

US Compound Feed Market By Ingredients (USD Billion, 2025-2035)

  • Cereals
  • Cereal By-Products
  • Oilseed Meal
  • Oils
  • Molasses
  • Supplements
  • Others

US Compound Feed Market By Supplements (USD Billion, 2025-2035)

  • Vitamins
  • Antibiotics
  • Antioxidants
  • Amino Acids
  • Enzymes
  • Acidifiers
  • Others

US Compound Feed Market By Livestock (USD Billion, 2025-2035)

  • Ruminants
  • Swine
  • Poultry
  • Aquaculture
  • Others
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.